Home > News > Genetic risk lab test utilises nanotechnology
August 25th, 2005
Genetic risk lab test utilises nanotechnology
Abstract:
The Optonanogen project, with support from the EU, aims to develop a system, which detect mutations of the BRCA1 gene responsible for between 2.5 and 5 per cent of the incidences of breast cancer in women. The final device will be roughly the size of a human hand, allowing it to be used in doctors' surgeries to determine the genetic predisposition of a patient to certain diseases in a matter of minutes.
Source:
labtechnologist.com
Bookmark:
| Related Links |
| Related News Press |
Possible Futures
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Sensors
Tiny nanosheets, big leap: A new sensor detects ethanol at ultra-low levels January 30th, 2026
From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||